LCI-LUN-ABR-001: A Pilot Study of Carboplatin With Nab-Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer of Squamous Histology
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Dec 2017
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 19 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Nov 2019.
- 19 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Nov 2019.
- 20 Jun 2017 Status changed from recruiting to active, no longer recruiting.